We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sharing Diagnostic Imaging from an iOs Device to Imaging Worklist

By MedImaging International staff writers
Posted on 19 Apr 2015
Image: Sharing a “Medical Selfie” Using an iPhone (Photo courtesy of DICOM Grid).
Image: Sharing a “Medical Selfie” Using an iPhone (Photo courtesy of DICOM Grid).
An open cloud mobile medical image management platform provider has unveiled a new feature at the annual Healthcare Information and Management Systems Society (HIMSS 2015; Chicago, IL, USA) Conference.

The feature enables a patient or caregiver to upload and share clinical and diagnostic images with physicians, in real time, using a mobile device running the iOs operating system. The feature is intended for sharing visible light images in a US Health Insurance Portability and Accountability Act(HIPAA) secure environment with expert consultants.

The DG Suite telemedicine/telehealth platform was developed by DICOM Grid (Phoenix, AZ, USA). The new “medical selfie” feature is intended for use in dermatology and wound care applications.

Morris Panner, CEO of DICOM Grid, said, "The ability to quickly send a picture is especially critical in trauma situations or frankly just to monitor ongoing care. For example, patients or referring physicians can snap a shot of a burn, wound, or other injury and share it with a specialty provider in minutes. A physician can view the picture through our secure portal to determine a treatment plan and advise whether or not the issue requires an in-person visit."

Related Links:

DICOM Grid
HIPAA


Computed Tomography System
Aquilion ONE / INSIGHT Edition
Radiation Safety Barrier
RayShield Intensi-Barrier
Portable X-ray Unit
AJEX140H
High-Precision QA Tool
DEXA Phantom

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.